Search research articles
Contact Us
Filters
Showing results (1-10 of 10) with videos related to
Page
of 1
Sort By:
Antioxidants (Basel, Switzerland)
|
September 28, 2021
Tocotrienols as an Anti-Breast Cancer Agent
Madison Trujillo, Anupreet Kharbanda, Christa Corley, et al.
European Journal of Medicinal Chemistry
|
August 22, 2021
Discovery of 4-aminoquinolines as highly selective TGFβR1 inhibitors with an attenuated MAP4K4 profile for potential applications in immuno-oncology
Anupreet Kharbanda, Phuc Tran, Lingtian Zhang, et al.
Medicinal Research Reviews
|
November 20, 2023
Revisiting Aurora Kinase B: A promising therapeutic target for cancer therapy
Naga Rajiv Lakkaniga, Zhengyu Wang, Yao Xiao, et al.
Journal of Medicinal Chemistry
|
September 25, 2019
The Exploration of Chirality for Improved Druggability within the Human Kinome
Debasmita Saha, Anupreet Kharbanda, Wei Yan, et al.
Chemical Communications (Cambridge, England)
|
October 31, 2018
Catalyst free, C-3 functionalization of imidazo[1,2-a]pyridines to rapidly access new chemical space for drug discovery efforts
Naresh Gunaganti, Anupreet Kharbanda, Naga Rajiv Lakkaniga, et al.
Tetrahedron
|
October 23, 2018
Selective, C-3 Friedel-Crafts acylation to generate functionally diverse, acetylated Imidazo[1,2-<i>a</i>]pyridine derivatives
Brendan Frett, Nicholas McConnell, Anupreet Kharbanda, et al.
European Journal of Medicinal Chemistry
|
July 11, 2021
Discovery and biological evaluation of phthalazines as novel non-kinase TGFβ pathway inhibitors
Anupreet Kharbanda, Lingtian Zhang, Debasmita Saha, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)
|
August 16, 2021
Destruction of DNA-Binding Proteins by Programmable Oligonucleotide PROTAC (O'PROTAC): Effective Targeting of LEF1 and ERG
Jingwei Shao, Yuqian Yan, Donglin Ding, et al.
European Journal of Medicinal Chemistry
|
September 3, 2021
Discovery of imidazo[1,2-a]pyridine-thiophene derivatives as FLT3 and FLT3 mutants inhibitors for acute myeloid leukemia through structure-based optimization of an NEK2 inhibitor
Lingtian Zhang, Naga Rajiv Lakkaniga, Jaideep B Bharate, et al.
Journal of Medicinal Chemistry
|
January 27, 2022
Discovery of N-Trisubstituted Pyrimidine Derivatives as Type I RET and RET Gatekeeper Mutant Inhibitors with a Novel Kinase Binding Pose
Lingtian Zhang, Marialuisa Moccia, David C Briggs, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 10) with videos related to
Sort By:
Page
of 1
Antioxidants (Basel, Switzerland)
|
September 28, 2021
Tocotrienols as an Anti-Breast Cancer Agent
Madison Trujillo, Anupreet Kharbanda, Christa Corley, et al.
European Journal of Medicinal Chemistry
|
August 22, 2021
Discovery of 4-aminoquinolines as highly selective TGFβR1 inhibitors with an attenuated MAP4K4 profile for potential applications in immuno-oncology
Anupreet Kharbanda, Phuc Tran, Lingtian Zhang, et al.
Medicinal Research Reviews
|
November 20, 2023
Revisiting Aurora Kinase B: A promising therapeutic target for cancer therapy
Naga Rajiv Lakkaniga, Zhengyu Wang, Yao Xiao, et al.
Journal of Medicinal Chemistry
|
September 25, 2019
The Exploration of Chirality for Improved Druggability within the Human Kinome
Debasmita Saha, Anupreet Kharbanda, Wei Yan, et al.
Chemical Communications (Cambridge, England)
|
October 31, 2018
Catalyst free, C-3 functionalization of imidazo[1,2-a]pyridines to rapidly access new chemical space for drug discovery efforts
Naresh Gunaganti, Anupreet Kharbanda, Naga Rajiv Lakkaniga, et al.
Tetrahedron
|
October 23, 2018
Selective, C-3 Friedel-Crafts acylation to generate functionally diverse, acetylated Imidazo[1,2-<i>a</i>]pyridine derivatives
Brendan Frett, Nicholas McConnell, Anupreet Kharbanda, et al.
European Journal of Medicinal Chemistry
|
July 11, 2021
Discovery and biological evaluation of phthalazines as novel non-kinase TGFβ pathway inhibitors
Anupreet Kharbanda, Lingtian Zhang, Debasmita Saha, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)
|
August 16, 2021
Destruction of DNA-Binding Proteins by Programmable Oligonucleotide PROTAC (O'PROTAC): Effective Targeting of LEF1 and ERG
Jingwei Shao, Yuqian Yan, Donglin Ding, et al.
European Journal of Medicinal Chemistry
|
September 3, 2021
Discovery of imidazo[1,2-a]pyridine-thiophene derivatives as FLT3 and FLT3 mutants inhibitors for acute myeloid leukemia through structure-based optimization of an NEK2 inhibitor
Lingtian Zhang, Naga Rajiv Lakkaniga, Jaideep B Bharate, et al.
Journal of Medicinal Chemistry
|
January 27, 2022
Discovery of N-Trisubstituted Pyrimidine Derivatives as Type I RET and RET Gatekeeper Mutant Inhibitors with a Novel Kinase Binding Pose
Lingtian Zhang, Marialuisa Moccia, David C Briggs, et al.
Page
of 1